RELATING TO TERMINAL ILLNESSES.
Summary
Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 14, 2026
Last action Jan 26, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
1
Jan 26, 2026
Committee
Referred to HHS, CPN/JDC.
upper
Jan 21, 2026
Introduced
Introduced and passed First Reading.
upper
Jan 14, 2026
Introduced
Pending Introduction.
upper
2 primary · 1 co-sponsor
Sponsors
Role
Legislator
Party
State
District
P
Kurt Fevella
RRepublican
P
Stanley Chang
DDemocratic
Co
Joy San Buenaventura
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 2221
Scope: HI
Hi! I can help you understand SB 2221. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline